Skip to main content

Advertisement

SpringerLink
Log in

A Review of the Association Between Depression and Insulin Resistance: Pitfalls of Secondary Analyses or a Promising New Approach to Prevention of Type 2 Diabetes?

  • MEDICOPSYCHIATRIC DISORDERS (WJ KATON, SECTION EDITOR)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

We review the validity of the evidence for an association between depression and the risk of insulin resistance (IR). We describe the potentially plausible biological and behavioral mechanisms that explain how depression increases the risk of IR and consequent overt diabetes. We have identified gaps in the literature to guide future research. Evidence for bidirectional associations between depression and IR is inconsistent. Results showing positive associations between depression and IR are derived from cross-sectional studies, whereas negative findings are typically reported in cohort studies. On the other hand, tentative trial evidence suggests that the effective treatment of depression can improve IR, and that lifestyle programs improve IR and reduce depressive symptoms. These emerging themes could lead to potential new multidisciplinary approaches to preventing diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. World Health Organization. The global burden of disease: 2004 Update. WHO Press; 2008.

  2. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464–70.

    Article  PubMed  Google Scholar 

  3. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–9.

    Article  PubMed  CAS  Google Scholar 

  4. ••Nouwen A, Nefs G, Caramlau I, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes. Diabetes Care. 2011;34(3):752–762. This review shows that the prevalence of depression is similar in people with pre-diabetes compared with those with normal fasting plasma glucose and undiagnosed diabetes, but higher in people with known diabetes.

    Article  PubMed  Google Scholar 

  5. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837–45.

    Article  PubMed  CAS  Google Scholar 

  6. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–90.

    Article  PubMed  Google Scholar 

  7. Lawlor DA, Smith GD, Ebrahim S. British Women’s Heart and Health study: association of insulin resistance with depression: cross sectional findings from the British Women’s Heart and Health study. BMJ. 2003;327(7428):1383–4.

    Article  PubMed  Google Scholar 

  8. Timonen M, Rajala U, Jokelainen J, et al. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol Psychiatry. 2006;11(10):929–33.

    Article  PubMed  CAS  Google Scholar 

  9. Timonen M, Salmenkaita I, Jokelainen J, et al. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med. 2007;69(8):723–8.

    Article  PubMed  Google Scholar 

  10. Adriaanse MC, Dekker JM, Nijpels G, et al. Associations between depressive symptoms and insulin resistance: the Hoorn study. Diabetologia. 2006;49(12):2874–7.

    Article  PubMed  CAS  Google Scholar 

  11. Pan A, Ye X, Franco OH, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord. 2008;109(1–2):75–82.

    Article  PubMed  CAS  Google Scholar 

  12. Holt RI, Phillips DI, Jameson KA, et al. The relationship between depression and diabetes mellitus: findings from the Hertfordshire cohort study. Diabet Med. 2009;26(6):641–8.

    Article  PubMed  CAS  Google Scholar 

  13. Pearson S, Schmidt M, Patton G, et al. Depression and insulin resistance: cross sectional associations in young adults. Diabetes Care. 2010;33(5):1128–33.

    Article  PubMed  CAS  Google Scholar 

  14. Golden SH, Lee HB, Schreiner PJ, et al. Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med. 2007;69(6):529–36.

    Article  PubMed  Google Scholar 

  15. Roos C, Lidfeldt J, Agardh CD, et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women’s Health in the Lund Area study. Metab Clin Exp. 2007;56(6):825–9.

    Article  PubMed  CAS  Google Scholar 

  16. Shen Q, Bergquist-Beringer S, Sousa VD. Major depressive disorder and insulin resistance in nondiabetic young adults in the United States: the National Health and Nutrition Examination Survey, 1999–2002. Biological Research for Nursing 2010. [Epub ahead of print].

  17. Lawlor DA, Ben-Shlomo Y, Ebrahim S, et al. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study. BMJ. 2005;330(7493):705–6.

    Article  PubMed  Google Scholar 

  18. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004;27(12):2856–62.

    Article  PubMed  Google Scholar 

  19. Chiba M, Suzuki S, Hinokio Y, et al. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metab Clin Exp. 2000;49(9):1145–9.

    Article  PubMed  CAS  Google Scholar 

  20. Hung YJ, Hsieh CH, Chen YJ, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol. 2007;67(5):784–9.

    Article  CAS  Google Scholar 

  21. Okamura F, Tashiro A, Utumi A, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism. 2000;49(10):1255–160.

    Article  PubMed  CAS  Google Scholar 

  22. Kauffman RP, Castracane VD, White DL, et al. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecol Endocrinol. 2005;21(3):129–37.

    Article  PubMed  CAS  Google Scholar 

  23. Weber-Hamann B, Gilles M, Lederbogen F, et al. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. J Clin Psychiatry. 2006;67(12):1856–61.

    Article  PubMed  CAS  Google Scholar 

  24. Chen YC, Lin WW, Chen YJ, et al. Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators of Inflammation; 2010. [Epub 2010 May 18].

  25. Atlantis E, Lange K, Goldney RD, et al. Specific medical conditions associated with clinically significant depressive symptoms in men. Soc Psychiatry Psychiatr Epidemiol 2010.

  26. Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117–24.

    Article  PubMed  CAS  Google Scholar 

  27. Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev. 2008;57:531–53.

    Article  PubMed  CAS  Google Scholar 

  28. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 2008;29:1110-a–1117.

    Article  Google Scholar 

  29. Champeri Wand GS, Malhotra SS, et al. Biological basis of depression in adults with diabetes. Curr Diabetes Rep. 2010;10(6):396–405.

    Article  Google Scholar 

  30. Pizzi C, Mancini S, Angeloni L, et al. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther. 2009;86:527–32.

    Article  PubMed  CAS  Google Scholar 

  31. Buhl ES, Jensen TK, Jessen N, et al. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. Am J Physiol Endocrinol Metab. 2010;298:E920–9.

    Article  PubMed  CAS  Google Scholar 

  32. Danese A, Pariante CM, Caspi A, et al. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA. 2007;104(4):1319–24.

    Article  PubMed  CAS  Google Scholar 

  33. Ismail K, Sloggett A, De Stavola B. Do common mental disorders increase cigarette smoking? Results from five waves of a population-based panel cohort study. Am J Epidemiol. 2000;152(7):651–7.

    Article  PubMed  CAS  Google Scholar 

  34. •Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–229. This systematic review showed for the first time bidirectional associations between obesity and depression, and provides support for the hypothesis that lifestyle behaviors (unhealthy eating and physical inactivity) mediate the association between depression and diabetes.

    Article  PubMed  Google Scholar 

  35. Patton GC, Carlin JB, Coffey C, et al. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998;88:1518–22.

    Article  PubMed  CAS  Google Scholar 

  36. van Gool CH, Kempen GIJM, Penninx BWJH, et al. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing. 2003;32:81–7.

    Article  PubMed  Google Scholar 

  37. Patten SB, Williams JVA, Lavorato DH, Eliasziw M: A longitudinal community study of major depression and physical activity. General Hospital Psychiatry; 2009;31:571–575.

    Google Scholar 

  38. Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry. 2003;60:817–26.

    Article  PubMed  Google Scholar 

  39. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008;51:1356–67.

    Article  PubMed  CAS  Google Scholar 

  40. Drewnowski A. The real contribution of added sugars and fats to obesity. Epidemiol Rev. 2007;29:160–71.

    Article  PubMed  Google Scholar 

  41. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451–63.

    Article  PubMed  CAS  Google Scholar 

  42. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623–34.

    Article  Google Scholar 

  43. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–403.

    Article  PubMed  Google Scholar 

  44. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166:2314–21.

    Article  PubMed  Google Scholar 

  45. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010;303:1921–8.

    Article  PubMed  CAS  Google Scholar 

  46. Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry. 2006;189:297–308.

    Article  PubMed  Google Scholar 

  47. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–20.

    Article  PubMed  CAS  Google Scholar 

  48. Simon GE, Rohde P, Ludman EJ, et al. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen Hosp Psychiatry. 2010;32:583–9.

    Article  PubMed  Google Scholar 

  49. •Ye Z, Chen L, Yang Z, et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One. 2011;6:e21551. This systematic review shows significant treatment effects of fluoxetine on reducing weight, triglyceride, and glycated hemoglobin levels in obese people with type 2 diabetes mellitus, which should be taken into account in the pharmacologic management of depression in individuals with excess body weight and diabetes.

    Article  PubMed  CAS  Google Scholar 

  50. Atlantis E, Goldney RD, Wittert GA. Obesity and depression or anxiety. BMJ. 2009;339:b3868.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. School of Medicine, King’s College London, London, SE1 1UL, England, UK

    Naomi Silva

  2. School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia

    Evan Atlantis

  3. Institute of Psychiatry, King’s College London, 10 Cutcombe Road, London, SE5 9RJ, England, UK

    Khalida Ismail

Authors
  1. Naomi Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evan Atlantis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khalida Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khalida Ismail.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, N., Atlantis, E. & Ismail, K. A Review of the Association Between Depression and Insulin Resistance: Pitfalls of Secondary Analyses or a Promising New Approach to Prevention of Type 2 Diabetes?. Curr Psychiatry Rep 14, 8–14 (2012). https://doi.org/10.1007/s11920-011-0245-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-011-0245-8

Keywords

Search

Navigation